Manohar Katakam, PH.D.

Founder & CEO


Experienced biotech/pharma entrepreneur with more than 25 years of experience in developing and marketing a diverse therapeutic area products. Dr. Katakam raised equity and debt capital and managed operations leading to many successful high-valued corporate exits. Major pharmaceutical industry experience included successful tenures at Centocor, Aventis, Wyeth, and Pfizer. Dr Katakam co-founded NuTherapeutics to develop and commercialize thin-film dosage forms of prescription products which he guided to a successful exit.

He established the orphan disease product company, Makindus, and led product development to Phase 3 readiness in both the US and in EU. He obtained his bachelor's degree in pharmacy from Kakatiya University and his MS and Ph.D. in Pharmaceutical Sciences from Auburn University.


David Johnston

Chief Financial Officer


Dave brings over thirty years of senior financial leadership experience.  Most recently he was Chief Financial Officer for ImmunoGen, Inc. an oncology focused biotech based in Waltham, MA.  During his tenure at ImmunoGen, he led several public offerings as well as a creative, non-dilutive royalty financing.  Prior to ImmunoGen, Dave served as CFO for Aveo Oncology and Genzyme Biosurgery where he lead both of their initial public offerings as well as leading several strategic initiatives, both on the buy-side as well as the sell-side.


Mr. Johnston earned a B.S. at Washington and Lee University and an MBA at the University of Michigan.  Mr. Johnston sat on the board of directors of RAW Art Works, a nonprofit youth arts organization, as well as Tissue Banks International, one of the largest eye and tissue bank non-profits in the United States.